HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN

November’s news roundup

This month’s top news stories.

Congenital hypopigmented macules on a healthy child

You are asked to evaluate an African American boy aged 4 years with a birthmark on his back and right arm. He is healthy with normal growth and development. What's the diagnosis?

Roflumilast cream safe, effective for atopic dermatitis in children 6 years and up

Recently announced data from the INTEGUMENT-1 phase 3 clinical trial demonstrated positive safety and efficacy results for atopic dermatitis patients 6 years and older treated with roflumilast cream (Arcutis Biotherapeutics).

Pfizer announces positive phase 3 data for RSV vaccine

Pfizer announced positive data from a phase 3 trial on a bivalent RSV vaccine.

Just a little birthmark?

You are asked to evaluate a healthy 1.5-day-old girl who has a congenital red patch with coarse telangiectasias and a surrounding ring of pallor on the right shoulder. What's your diagnosis?

Facial birthmark and new-onset seizures in infant

The parents of a 3-month-old girl seek medical advice regarding recent seizures and a facial birthmark. What’s the diagnosis?

Does stimulant medication for pediatric ADHD affect adult height?

A recent review found that multiple clinical trials indicated a reduction in adult height potential for children with long-term use of stimulant medication for treatment of ADHD, but other studies conflict with this data.

COVID-19 vaccine effective in adolescents

A real-world study determined the efficacy of mRNA vaccines for protection against COVID-19 in adolescents.

Increased neurologic involvement from COVID-19 in 2021

In a recent study, investigators found that life-threatening neurologic conditions from severe acute COVID-19 were more frequent in 2021 than 2020.

AAP: How to manage the surge of respiratory infections

In a recent statement, the American Academy of Pediatrics discussed how patients with respiratory infections can be managed, along with guidance on RSV treatment.

RSV, influenza, and COVID-19: Gearing up for the threat of a 'triple epidemic'

Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, sits down to discuss the rising threat of a "triple epidemic" consisting of influenza, COVID-19, and RSV in children.